Former commissioner Andrew von Eschenbach suggested an external group may offer the best chance for the US Food and Drug Administration to determine the best lessons learned by lessons from the coronavirus pandemic.
During an 18 May Food and Drug Law Institute Annual Conference session, von Eschenbach, now president of Samaritan Health Initiatives,...






